I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
HMGCLL1 is a predictive biomarker for deep molecular respon..:
Park, JH
;
Woo, YM
;
Youm, EM
...
http://hdl.handle.net/1959.4/unsworks_67451. , 2019
Link:
http://hdl.handle.net/1959.4/unsworks_67451
RT Journal T1
HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia
UL https://suche.suub.uni-bremen.de/peid=base-ftunswworks:oai:unsworks.library.unsw.edu.au:1959.4_unsworks_67451&Exemplar=1&LAN=DE A1 Park, JH A1 Woo, YM A1 Youm, EM A1 Hamad, N A1 Won, HH A1 Naka, K A1 Park, EJ A1 Kim, HJ A1 Kim, SH A1 Ahn, JS A1 Sohn, SK A1 Moon, JH A1 Jung, CW A1 Park, S A1 Lipton, JH A1 Kimura, S A1 Kim, JW A1 Kim, DH PB Springer Nature YR 2019 K1 Biotechnology K1 Cancer K1 Hematology K1 Stem Cell Research K1 Genetics K1 Clinical Research K1 Rare Diseases K1 Stem Cell Research - Nonembryonic - Human K1 4 Detection K1 screening and diagnosis K1 4.1 Discovery and preclinical testing of markers and technologies K1 Adolescent K1 Adult K1 Aged K1 80 and over K1 Apoptosis K1 Biomarkers K1 Tumor K1 Case-Control Studies K1 Cell Survival K1 Cohort Studies K1 Drug Resistance K1 Neoplasm K1 Female K1 Follow-Up Studies K1 Gene Expression Regulation K1 Neoplastic K1 Humans K1 Imatinib Mesylate K1 Leukemia K1 Myelogenous K1 Chronic K1 BCR-ABL Positive K1 Male K1 Middle Aged K1 Mutation K1 Oxo-Acid-Lyases K1 Prognosis K1 Protein Kinase Inhibitors K1 Survival Rate K1 Tumor Cells K1 Cultured K1 Young Adult K1 anzsrc-for: 1103 Clinical Sciences K1 anzsrc-for: 1112 Oncology and Carcinogenesis JF http://hdl.handle.net/1959.4/unsworks_67451 LK http://hdl.handle.net/1959.4/unsworks_67451 DO http://hdl.handle.net/1959.4/unsworks_67451 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)